Infectious Diseases in Obstetrics and Gynecology / 2011 / Article / Tab 2

Research Article

Prevalence of and Barriers to Dual-Contraceptive Methods Use among Married Men and Women Living with HIV in India

Table 2

Use of contraceptives before and after HIV diagnosis as reported by married persons living with HIV in India.

Contraceptive useBefore HIV diagnosisAfter HIV diagnosis
Men ( )Women ( )Men ( )Women ( ) valuea

Any contraceptive method28 (30.1%)26 (26.8%)89 (95.7%)92 (94.8%)<0.001
Condom use14 (15.1%)11 (11.3%)86 (92.5%)89 (91.8%)<0.001
Effective pregnancy prevention methods
 Oral hormonal contraception (“the pill”)2 (2.2%)6 (6.2%)3 (3.2%)10 (10.3%)0.33
 Intrauterine device4 (4.3%)6 (6.2%)1 (1.1%)0 (0%)b
 Injectables1 (1.1%)1 (1.0%)0 (0.0%)1 (1.0%)
 Tubal ligation9 (9.7%)9 (9.3%)11 (11.8%)19 (19.6%)<0.01
 Vasectomy1 (1.1%)0 (0.0%)3 (3.2%)1 (1.0%)
Any effective pregnancy prevention method17 (18.3%)20 (20.6%)17 (18.3%)30 (30.9%)0.20
Dual-contraceptive methods4 (4.3%)5 (5.2%)14 (15.1%)29 (29.9%)<0.001
Ineffective pregnancy prevention methods
 Spermicide1 (1.1%)0 (0.0%)0 (0.0%)0 (0.0%)
 Calendar method3 (3.2%)1 (1.0%)1 (1.1%)1 (1.0%)

a value for the change in contraceptive use among men and women combined.
bNumbers too small to assess change.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.